For instance, the 2021 ESC Guidelines for Valvular Heart Disease recommend natriuretic peptide measurement only in select asymptomatic patients with preserved ejection fraction – underscoring a conservative approach that positions NT-proBNP as a secondary, rather than primary, clinical tool.1 Here, NPPB is linked to heart valve disorder.